Hepatic ALT Waterfall Prototype

For trials that enrol participants with elevated baseline ALT but normal baseline bilirubin, where eDISH's ×ULN quadrants lose their meaning — a floating bar per participant from their own baseline ALT to their maximum on-treatment ALT in absolute U/L, ranked by baseline so the two arms' highest baselines meet at the seam, blue for placebo and bronze for active drug with new-onset jaundice in green, flanked by a box-and-whisker summary per arm (Amirzadegan et al., Drug Safety 2025, Figure 5).

This live demo mounts the committed dist/safety.viz-1.7.0 IIFE bundle — the same asset gsm.safety vendors — against real example data (adbds-abnbl.csv, built from the pharmaverseadam CDISC Pilot 01 ADaM datasets), with the full control panel active.